共 17 条
[1]
[Anonymous], 1996, NOTE GUIDANCE VALIDA
[2]
Bolton S., 1997, PHARM STAT PRACTICAL, P216
[3]
Imatinib as a paradigm of targeted therapies
[J].
ADVANCES IN CANCER RESEARCH, VOL 91,
2004, 91
:1-+
[5]
Hochhaus A., 2004, Annals of Hematology, V83, pS65
[6]
Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in Glivec® capsules
[J].
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,
2004, 800 (1-2)
:253-258
[8]
LEVITZKI A, 2002, ENCY CANC, P475
[9]
LEWIS GA, 1999, PHARM EXPT DESIGN, P79

